Polysialic acid-Siglec immune checkpoints of microglia and macrophages: Perspectives for therapeutic intervention

Polysialic acid-Siglec immune checkpoints of microglia and macrophages: Perspectives for therapeutic intervention

Saved in:

Bibliographic Details
Main Authors:	Hauke Thiesler, Herbert Hildebrandt
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-02-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-01195
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Polysialic acid is upregulated on activated immune cells and negatively regulates anticancer immune activity
by: Olivia Drummond-Guy, et al.
Published: (2025-03-01)

Study of polysialated recombinant human insulin
by: M. N. Korchagnikova, et al.
Published: (2009-04-01)

Siglecs-mediated immune regulation in neurological disorders
by: Huifang Tu, et al.
Published: (2024-12-01)

Chemical and Enzymatic Synthesis of DisialylGb5 and Other Sialosides for Glycan Array Assembly and Evaluation of Siglec-Mediated Immune Checkpoint Inhibition
by: Kuo-Shiang Liao, et al.
Published: (2025-05-01)

NCAM and attached polysialic acid affect behaviors of breast epithelial cells through differential signaling pathways
by: Wu Yurong, et al.
Published: (2024-10-01)

Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
by: Yan Huang, et al.
Published: (2023-09-01)

Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina
by: Marcus Karlstetter, et al.
Published: (2016-12-01)

Comprehensive Modular Synthesis of Ganglioside Glycans and Evaluation of their Binding Affinities to Siglec‐7 and Siglec‐9
by: Avijit K. Adak, et al.
Published: (2025-01-01)

A highly sensitive quantitative method of polysialic acid reveals its unique changes in brain aging and neuropsychiatric disorders
by: Masaya Hane, et al.
Published: (2025-05-01)

Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity
by: Husam Nawafleh, et al.
Published: (2024-10-01)

Development of a permethylation-based detection method for oligo/polysialic acid structures via tandem MALDI-TOF mass spectrometry
by: Kai Suzuki, et al.
Published: (2025-01-01)

Editorial: Microglia and tissue macrophages in pain
by: Darian Mohsenin, et al.
Published: (2025-08-01)

Siglec-15 antibody–GM-CSF chimera suppresses tumor progression via reprogramming tumor-associated macrophages
by: Jun Li, et al.
Published: (2025-04-01)

Rational design of FVIII sialylated peptides to target Siglec-3 and Siglec-9 and improve peptide formulations for reverse vaccines
by: Eleonora Nardini, et al.
Published: (2025-04-01)

Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.
by: Yung-Chi Chang, et al.
Published: (2014-01-01)

Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma
by: Yuchen Zhang, et al.
Published: (2025-01-01)

Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis
by: Ying Wu, et al.
Published: (2025-03-01)

Immuno-PET Imaging of Siglec-15 Using the Zirconium-89-Labeled Therapeutic Antibody, NC318
by: Elaine M. Jagoda, et al.
Published: (2023-01-01)

Commentary on “Targeted release of a bispecific fusion protein SIRPα/Siglec-10 by oncolytic adenovirus reinvigorates tumor-associated macrophages to improve therapeutic outcomes in solid tumors”
by: Marc Lecoultre, et al.
Published: (2025-06-01)

SIGLEC11 promotes M2 macrophage polarization through AKT–mTOR signaling and facilitates the progression of gastric cancer
by: Chen Li, et al.
Published: (2025-01-01)

Siglec6 CAR T cells suppressed progression of AML via inhibiting Siglec6 and SHP2 induced Src and ERK signaling activation
by: Qian Li, et al.
Published: (2025-05-01)

The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer
by: Jie Yin, et al.
Published: (2017-01-01)

Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients
by: Hamza Benthami, et al.
Published: (2025-06-01)

Enhancing antitumor immunity: the role of immune checkpoint inhibitors, anti-angiogenic therapy, and macrophage reprogramming
by: Chong Zhang, et al.
Published: (2025-04-01)

Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
by: Keaton I Jones, et al.
Published: (2018-11-01)

Alcohol induces α2‐6sialo mucin O‐glycans that kill U937 macrophages mediated by sialic acid‐binding immunoglobulin‐like lectin 7 (Siglec 7)
by: Pi‐Wan Cheng, et al.
Published: (2025-01-01)

Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors
by: Besan H. Alsaafeen, et al.
Published: (2025-04-01)

Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma
by: Fen Liu, et al.
Published: (2025-08-01)

Phosphoproteomics identifies microglial Siglec‐F inflammatory response during neurodegeneration
by: Nader Morshed, et al.
Published: (2020-12-01)

Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies
by: Anna Carolina Carvalho da Fonseca, et al.
Published: (2013-01-01)

Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade
by: Yan Zhang, et al.
Published: (2019-08-01)

Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors
by: Jiyuan Yang, et al.
Published: (2025-08-01)

Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies
by: Haiqing Jia, et al.
Published: (2025-07-01)

Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment
by: Anqi Lin, et al.
Published: (2025-01-01)

Construction of a macrophage-related prognostic signature and assessment of immune checkpoint inhibitor efficacy of HCC
by: Shouge Zang, et al.
Published: (2025-07-01)

The APOE–Microglia Axis in Alzheimer’s Disease: Functional Divergence and Therapeutic Perspectives—A Narrative Review
by: Aiwei Liu, et al.
Published: (2025-06-01)

The roles of glioma-associated macrophages/microglia and potential targets for anti-glioma therapy
by: Hiroaki Matsuzaki, et al.
Published: (2025-01-01)

Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite
by: Giorgia Renga, et al.
Published: (2022-03-01)

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms
by: Zhijiang Chen, et al.
Published: (2024-10-01)

Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics
by: B.E. Nelson, et al.
Published: (2025-03-01)